Published in Trans Assoc Am Physicians on January 01, 1974
Diagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis. Curr Opin Endocrinol Diabetes Obes (2014) 0.87
Comparative analysis of serum antibody responses to Pseudomonas aeruginosa exotoxin A by cystic fibrosis and intensive care unit patients. J Clin Microbiol (1983) 0.86
Effects of iodine on thyroid function in man. Trans Am Clin Climatol Assoc (1991) 0.83
A Multi-Breed Genome-Wide Association Analysis for Canine Hypothyroidism Identifies a Shared Major Risk Locus on CFA12. PLoS One (2015) 0.80
Environmental factors altering thyroid function and their assessment. Environ Health Perspect (1981) 0.78
Antithyroid action of carbocisteine. Br Med J (Clin Res Ed) (1986) 0.75
Thyroid Function in Patients with Cystic Fibrosis: No Longer a Concern? Thyroid (2016) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
A gene map of the human genome. Science (1996) 14.32
Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol (2003) 9.10
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
A systematic, high-resolution linkage of the cytogenetic and physical maps of the human genome. Nat Genet (2000) 4.78
Dynamic association of capping enzymes with transcribing RNA polymerase II. Genes Dev (2000) 4.47
Common VKORC1 and GGCX polymorphisms associated with warfarin dose. Pharmacogenomics J (2005) 3.75
Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994) J Clin Endocrinol Metab (1998) 3.69
Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA (1995) 3.68
Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J Clin Invest (1970) 3.64
Three functional classes of transcriptional activation domain. Mol Cell Biol (1996) 3.62
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab (2003) 3.24
Adverse effects of iodides on thyroid function. Med Clin North Am (1975) 2.86
Disoriented pathfinding by pioneer neurone growth cones deprived of filopodia by cytochalasin treatment. Nature (1986) 2.57
The effect of short-term low-dose perchlorate on various aspects of thyroid function. Thyroid (2000) 2.54
A SNP resource for human chromosome 22: extracting dense clusters of SNPs from the genomic sequence. Genome Res (2001) 2.49
Inorganic phosphate treatment of hypercalcemia of diverse etiologies. N Engl J Med (1966) 2.46
A new method for measuring the free thyroid hormone in human serum and an analysis of the factors that influence its concentration. J Clin Invest (1965) 2.29
Stimulation by phagocytosis of the deiodination of L-thyroxine in human leukocytes. Science (1972) 2.26
Reproductive failure in males with cystic fibrosis. N Engl J Med (1968) 2.22
Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med (1997) 2.20
PANCREATIC FUNCTION AND DISEASE IN EARLY LIFE. I. PANCREATIC ENZYME ACTIVITY AND THE CELIAC SYNDROME. J Clin Invest (1943) 2.17
A report on sixty-five patients over 17 years of age. Pediatrics (1965) 2.13
Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. J Clin Endocrinol Metab (1997) 2.11
Presumptive tests for cystic fibrosis based on serum protein in meconium. Pediatrics (1968) 2.09
Cystic fibrosis: a new outlook. 70 patients above 25 years of age. Medicine (Baltimore) (1977) 2.01
Molecular heterogeneity of the fragile X syndrome. Nucleic Acids Res (1991) 2.00
Studies in cystic fibrosis. Report of 130 patients diagnosed under 3 months of age over a 20-year period. Pediatrics (1970) 1.95
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab (1999) 1.92
The guanylyltransferase domain of mammalian mRNA capping enzyme binds to the phosphorylated carboxyl-terminal domain of RNA polymerase II. J Biol Chem (1998) 1.91
Suppression of thyroid radioiodine uptake by various doses of stable iodide. N Engl J Med (1980) 1.88
Activated transcription independent of the RNA polymerase II holoenzyme in budding yeast. Genes Dev (1998) 1.83
Microtubule behavior during guidance of pioneer neuron growth cones in situ. J Cell Biol (1991) 1.83
Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. Science (1987) 1.80
Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid (1998) 1.76
Isolation of a putative transcriptional regulator from the region of 22q11 deleted in DiGeorge syndrome, Shprintzen syndrome and familial congenital heart disease. Hum Mol Genet (1993) 1.76
The effects of amiodarone on the thyroid. Endocr Rev (2001) 1.75
Intussusception in patients with cystic fibrosis. Pediatrics (1971) 1.71
Induction of myxedema by iodide in patients euthyroid after radioiodin or surgical treatment of diffuse toxic goiter. N Engl J Med (1969) 1.70
Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology (1999) 1.70
A review of 164 children with meconium ileus seen at the Children's Hospital Medical Center, Boston. Pediatrics (1966) 1.68
Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. J Clin Endocrinol Metab (1996) 1.68
The management of portal hypertension in cystic fibrosis. J Pediatr Surg (1977) 1.66
Ammonium persulfate: a safe alternative oxidizing reagent for measuring urinary iodine. Clin Chem (1996) 1.64
Appropriate cutoff values of anthropometric variables to predict cardiovascular outcomes: 7.6 years follow-up in an Iranian population. Int J Obes (Lond) (2009) 1.63
Intestinal transport of amino acid residues of dipeptides. I. Influx of the glycine residue of glycyl-L-proline across mucosal border. J Biol Chem (1971) 1.63
Diversion of peripheral thyroxine metabolism from activating to inactivating pathways during complete fasting. J Clin Endocrinol Metab (1975) 1.62
The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). Diabetes Obes Metab (2008) 1.59
Follow-up study of male and female offspring of DES-exposed mothers. Obstet Gynecol (1977) 1.58
Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med (1996) 1.57
Low dose perchlorate (3 mg daily) and thyroid function. Thyroid (2001) 1.57
Intestinal lymphagiectasia: a reappraisal. Pediatrics (1975) 1.52
Pioneer growth cone steering decisions mediated by single filopodial contacts in situ. J Neurosci (1990) 1.52
National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J Clin Endocrinol Metab (2007) 1.52
Prevalence of coronary heart disease among Tehran adults: Tehran Lipid and Glucose Study. East Mediterr Health J (2009) 1.49
Quantitative assay of disaccharidase activities of small intestinal mucosal biopsy specimens in infancy and childhood. Pediatrics (1965) 1.46
Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients. Ann Intern Med (1989) 1.46
Tear glucose detection of hyperglycemia. Am J Ophthalmol (1968) 1.45
Accumulation of actin in subsets of pioneer growth cone filopodia in response to neural and epithelial guidance cues in situ. J Cell Biol (1993) 1.43
Whole-grain consumption and the metabolic syndrome: a favorable association in Tehranian adults. Eur J Clin Nutr (2005) 1.42
The sweat test: sodium and chloride values. J Pediatr (1981) 1.42
The effect of diltiazem, a calcium channel-blocking drug, on cardiac rate and rhythm in hyperthyroid patients. Arch Intern Med (1988) 1.41
The effects of an acute load of thyroxine on the transport and peripheral metabolism of triiodothyronine in man. J Clin Invest (1970) 1.41
Conjugal Graves disease. Ann Intern Med (1992) 1.39
Iodide-induced hypothyroidism: a potential hazard during perinatal life. Science (1979) 1.39
The aging thyroid. Increased prevalence of elevated serum thyrotropin levels in the elderly. JAMA (1979) 1.38
Induction of filopodia by direct local elevation of intracellular calcium ion concentration. J Cell Biol (1999) 1.38
Effects of fibroblast growth factor on type I 5'-deiodinase in FRTL-5 rat thyroid cells. Endocrinology (1994) 1.37
Nitric oxide binding to oxygenated hemoglobin under physiological conditions. Biochim Biophys Acta (2001) 1.37
Evaluation of a simplified technique for the specific measurement of serum thyroxine concentration. J Clin Endocrinol Metab (1971) 1.34
The peripheral metabolism of triiodothyronine in normal subjects and in patients with hyperthyroidism. J Clin Invest (1970) 1.34
Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves'-IgG. Endocrinology (1986) 1.33
The effect of starvation on the concentration and binding of thyroxine and triiodothyronine in serum and on the response to TRH. J Clin Endocrinol Metab (1974) 1.32
Chronic plumbism in children. Diagnosis by hair analysis. JAMA (1969) 1.32
Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. J Endocrinol Invest (1986) 1.31
Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr Metab Cardiovasc Dis (2008) 1.29
Clinical review 169: Interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects. J Clin Endocrinol Metab (2004) 1.28
Preparation of I-131-labeled human serum prealbumin and its metabolism in normal and sick patients. J Clin Invest (1965) 1.28
Protracted diarrhea of infancy treated by intravenous alimentation. I. Clinical studies of 16 infants. Am J Dis Child (1973) 1.27
Antimicrobial use in long-term-care facilities. Infect Control Hosp Epidemiol (1996) 1.27
Childhood obesity in the Middle East: a review. East Mediterr Health J (2010) 1.26
Quantitative staging of embryonic development of the grasshopper, Schistocerca nitens. J Embryol Exp Morphol (1979) 1.26
The contribution of thyroxine-binding prealbumin to the binding of thyroxine in human serum, as assessed by immunoadsorption. J Clin Invest (1968) 1.26
Gastrointestinal manifestations of cystic fibrosis. Pediatr Clin North Am (1975) 1.25
Genomic sequence and transcriptional profile of the boundary between pericentromeric satellites and genes on human chromosome arm 10q. Hum Mol Genet (2000) 1.25
Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men--a 3.6-year prospective study. Exp Clin Endocrinol Diabetes (2006) 1.24
Waist-to-hip ratio is a better screening measure for cardiovascular risk factors than other anthropometric indicators in Tehranian adult men. Int J Obes Relat Metab Disord (2004) 1.24
The sweat test in cystic fibrosis. A comparison of overnight sweat collection versus the pilocarpine iontophoresis method. J Pediatr (1966) 1.22
Fasciclin IV: sequence, expression, and function during growth cone guidance in the grasshopper embryo. Neuron (1992) 1.22
Lymphocytic thyroiditis and diabetes in the BB/W rat. A new model of autoimmune endocrinopathy. Diabetes (1981) 1.22
Specificity of VO2MAX and the ventilatory threshold in free swimming and cycle ergometry: comparison between triathletes and swimmers. Br J Sports Med (2005) 1.21